Columbia Research Enhanced Etf Performance

REVS Etf  USD 26.96  0.01  0.04%   
The etf shows a Beta (market volatility) of 0.76, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Columbia Research's returns are expected to increase less than the market. However, during the bear market, the loss of holding Columbia Research is expected to be smaller as well.

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Columbia Research Enhanced are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Columbia Research may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
1
Bond ETFs Added 9B Last Week as Stock Funds Bled Cash - etf.com
09/09/2024
2
Tesla revs up for action-packed October with Q3 deliveries, Robotaxi event ahead - Investing.com Canada
09/27/2024
3
Morning Bid Post-election dollar revs up, China battles deflation - Yahoo Canada Finance
11/11/2024
In Threey Sharp Ratio0.37
  

Columbia Research Relative Risk vs. Return Landscape

If you would invest  2,495  in Columbia Research Enhanced on August 29, 2024 and sell it today you would earn a total of  201.00  from holding Columbia Research Enhanced or generate 8.06% return on investment over 90 days. Columbia Research Enhanced is currently generating 0.1235% in daily expected returns and assumes 0.6898% risk (volatility on return distribution) over the 90 days horizon. In different words, 6% of etfs are less volatile than Columbia, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Columbia Research is expected to generate 1.06 times less return on investment than the market. But when comparing it to its historical volatility, the company is 1.12 times less risky than the market. It trades about 0.18 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.17 of returns per unit of risk over similar time horizon.

Columbia Research Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Columbia Research's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Columbia Research Enhanced, and traders can use it to determine the average amount a Columbia Research's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.179

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashREVSAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 0.69
  actual daily
6
94% of assets are more volatile

Expected Return

 0.12
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.18
  actual daily
14
86% of assets perform better
Based on monthly moving average Columbia Research is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Columbia Research by adding it to a well-diversified portfolio.

Columbia Research Fundamentals Growth

Columbia Etf prices reflect investors' perceptions of the future prospects and financial health of Columbia Research, and Columbia Research fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Columbia Etf performance.

About Columbia Research Performance

Assessing Columbia Research's fundamental ratios provides investors with valuable insights into Columbia Research's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Columbia Research is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
The fund invests at least 80 percent of its assets in the securities of the index. Columbia Research is traded on NYSEARCA Exchange in the United States.
Latest headline from news.google.com: Morning Bid Post-election dollar revs up, China battles deflation - Yahoo Canada Finance
The fund maintains 99.7% of its assets in stocks
When determining whether Columbia Research is a strong investment it is important to analyze Columbia Research's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Columbia Research's future performance. For an informed investment choice regarding Columbia Etf, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Columbia Research Enhanced. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
The market value of Columbia Research is measured differently than its book value, which is the value of Columbia that is recorded on the company's balance sheet. Investors also form their own opinion of Columbia Research's value that differs from its market value or its book value, called intrinsic value, which is Columbia Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Columbia Research's market value can be influenced by many factors that don't directly affect Columbia Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Columbia Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if Columbia Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Columbia Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.